{"result": {"id": "chatcmpl-70", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Ovarian Cancer Research Community\",\n    \"summary\": \"This report analyzes the Ovarian Cancer Research community, focusing on its key entities and their interrelationships. The community comprises researchers, clinicians, and patients working to understand and combat ovarian cancer.  It highlights the interconnectedness of these entities and their impact on research progress.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The Ovarian Cancer Research Community is a highly impactful entity due to its direct contribution to patient care and scientific advancement in the field of oncology. The community's influence extends across multiple disciplines and geographical locations, making it a significant force for progress.\",\n    \"findings\": [\n        {\n            \"summary\": \"Ovarian cancer research is driven by a diverse group of entities with specialized expertise.\",\n            \"explanation\": \"The Ovarian Cancer Research Community comprises researchers from various fields, including oncologists, pathologists, geneticists, and immunologists. These experts collaborate to develop innovative treatments and diagnostic tools. The community also includes clinicians who provide patient care and support, as well as patients who contribute their experiences and insights to research efforts. This diverse group of individuals brings a wide range of perspectives and expertise to the field, fostering innovation and progress in ovarian cancer research.\"\n        },\n        {\n            \"summary\": \"Significant advancements have been made in understanding and treating ovarian cancer.\",\n            \"explanation\": \"The Ovarian Cancer Research Community has achieved significant breakthroughs in understanding the disease's biology and developing new treatment strategies.  For example, targeted therapies like PARP inhibitors have revolutionized treatment for certain subtypes of ovarian cancer. Additionally, research into early detection methods and personalized medicine is ongoing, aiming to improve patient outcomes and reduce the impact of this devastating disease.\"\n        },\n        {\n            \"summary\": \"The Ovarian Cancer Research Community faces challenges in funding and access to resources.\",\n            \"explanation\": \"Despite significant progress, the Ovarian Cancer Research Community continues to face challenges.  Limited funding for research, particularly for early-stage projects, can hinder innovation. Additionally, disparities in access to healthcare and treatment options remain a concern, impacting patient outcomes and requiring further attention.\"\n        },\n        {\n            \"summary\": \"Collaboration is crucial for advancing ovarian cancer research.\",\n            \"explanation\": \"The Ovarian Cancer Research Community thrives on collaboration.  Interdisciplinary teams of researchers from different institutions work together to share knowledge, resources, and expertise. This collaborative approach fosters innovation and accelerates progress in the field.\"\n        },\n        {\n            \"summary\": \"Patient engagement is essential for driving research progress.\",\n            \"explanation\": \"Patients are integral to the Ovarian Cancer Research Community.  Their lived experiences provide valuable insights into the disease's impact, informing research priorities and shaping treatment strategies. Patient advocacy groups play a crucial role in connecting researchers with patients and ensuring their voices are heard.\"\n        },\n        {\n            \"summary\": \"The Ovarian Cancer Research Community is constantly evolving.\",\n            \"explanation\": \"The Ovarian Cancer Research Community is dynamic and ever-evolving.  New technologies, discoveries, and research initiatives emerge regularly, shaping the future of ovarian cancer treatment and prevention. The community must adapt to these changes and embrace innovation to continue making progress in this field.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743329820, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 696, "prompt_tokens": 2048, "total_tokens": 2744, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1937,PSC CELLS,Cells that are part of the human body,3\n531,TUMOR ANGIOGENESIS,\"**Tumor angiogenesis** refers to the process of forming new blood vessels. This process is essential for tumor growth and spread because it provides the necessary nutrients and oxygen for the tumor cells to proliferate and metastasize (spread) to other parts of the body.  Angiogenesis plays a critical role in tumor development and metastasis. \n\",8\n995,GLIOMA,\"Gliomas are a type of brain tumor that is also classified as a type of cancer.  They are the most common type of primary brain tumor, and are often studied in research to understand their development and treatment options. \n\",6\n105,VEGFA,\"**VEGFA**, also known as **Vascular Endothelial Growth Factor A**, is a protein that plays a crucial role in angiogenesis, the formation of new blood vessels. It's a key target for the gene **ZKSCAN3** and is involved in cell signaling and growth.  VEGFA acts as an angiogenic factor, promoting the growth of blood vessels.  It has been identified as a hotspot in human protein studies due to its significant role in various biological processes. \n\",16\n996,IDO1,\"IDO1 (also known as Indoleamine 2,3-dioxygenase 1) is a protein that plays a crucial role in angiogenesis and tumor growth. It functions as an enzyme involved in the breakdown of the amino acid tryptophan, which can inhibit immune responses and promote tumor development.  \n\",3\n3036,YTHDC2,A protein that is part of a larger family of proteins,3\n1586,TYPE 3 MACULAR NEOVASCULARIZATION,,2\n2227,MIR-1249,MicroRNA,2\n30,AKT,\"The **AKT** protein is a crucial player in both cancer and cell signaling. It functions as an enzyme, specifically a protein kinase B, which plays a significant role in regulating cell growth and migration.  AKT's involvement in cell signaling makes it essential for various cellular processes, including those related to cancer development. \n\",1\n2222,CIRC_0059914,A circRNA studied for its role in glioma,4\n3035,AC092100.1,\"The entity **AC092100.1** is a gene that has been identified as overexpressed and plays a significant role in alleviating fetal growth disorder.  It also promotes the proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs). Additionally, research on this specific long non-coding RNA is being conducted to understand its potential involvement in pre-eclampsia. \n\",3\n137,HUVEC,\"The **HUVEC** is a type of cell used in research, particularly for studying skin wound healing. It is a human umbilical vein endothelial cell line, commonly referred to as a cell line used for research on tube-forming assays.  HUVECs are also known as human umbilical vascular endothelial cells and can be found in various research settings. \n\",13\n1436,CBX7,\"The **CBX7** protein plays a significant role in angiogenesis, the formation of new blood vessels.  It enhances hypoxia-induced VEGF expression and angiogenesis in hepatocellular carcinoma (HCC) cells. Additionally, CBX7 is upregulated in hypoxic human choroidal vascular endothelial cells, indicating its involvement in vascular development under low oxygen conditions. This protein's ability to promote angiogenesis makes it a potential target for therapeutic interventions aimed at stimulating blood vessel formation in various diseases. \n\",5\n296,HIF-1Α,\"The **HIF-1α** protein plays a role in **angiogenesis**, the formation of new blood vessels.  Its activity is measured by analyzing plasma levels, which are determined using an **ELISA** (enzyme-linked immunosorbent assay) method. \n\",9\n2283,EXOSOME,Exosomes are nano-sized vesicles released by cells,1\n1390,MATRIGEL PLUG,\"The **Matrigel Plug** is a gel used in various biological research applications. It serves as a three-dimensional matrix that supports the growth and development of cells, enabling researchers to create structures for studying cell behavior.  This gel is also utilized in angiogenesis assays, where it helps assess the potential of tissues to form new blood vessels (angiogenesis). Additionally, Matrigel Plug can be used to test the angiogenic potential of different tissues. \n\",1\n5075,TUBE-FORMING ASSAY,,1\n5080,APJ,,1\n4689,NE,Norepinephrine is a hormone,4\n2122,OVARIAN CANCER SIDE POPULATION (SP),Cells in Ovarian Cancer,4\n3037,PE,Animal model used to study the effects of YTHDC2 on fetal mouse development,3\n1445,HYPOXIC CVECS,Cells that are affected by low oxygen levels,2\n2120,OVARIAN CANCER,\"**Ovarian cancer** is a type of **gynecological malignancy**, a form of cancer affecting the ovaries.  It is a serious disease that affects women's reproductive organs, and can be fatal. \n\",7\n2173,EC TARGET DELIVERY,Process of delivering siRNA to tumor cells,3\n1442,CVECS,Cardiovascular endothelial cells,1\n4231,HLA-G,\"The **HLA-G** protein is a crucial component of the immune system, playing a role in regulating immune responses. It functions as an immunosuppressant by suppressing angiogenesis, the formation of new blood vessels. Additionally, HLA-G has been implicated in myeloma cell growth, highlighting its complex and multifaceted role in various biological processes. \n\",1\n3407,OV-EVS,Ovarian cancer cells used for research,2\n3137,CAFS,\"**CAFS (Cancer-associated fibroblasts)** are a type of cell that plays a significant role in the progression of cancer.  They contribute to cancer cell spread and can be targeted for therapeutic intervention. \n\",4\n3138,PODOPLANIN,Protein that labels CAF subpopulations with pro-angiogenic functions,4\n92,RECURRENT PREGNANCY LOSS,\"**Recurrent Pregnancy Loss**, also known as **repeated pregnancy loss**, is defined as the termination of two or more pregnancies before 20 weeks of gestation. This condition can be a significant cause of concern for individuals and families, often leading to emotional distress and uncertainty about future pregnancies.  It's important to note that recurrent pregnancy loss encompasses any pregnancy ending before 20 weeks of gestation. \n\",4\n1072,PLACENTA,\"The **placenta** is a vital organ that connects the mother's and baby's circulatory systems, facilitating nutrient and waste exchange. It plays a crucial role in supporting fetal development by providing oxygen and essential nutrients to the growing fetus.  The placenta also serves as a site for the production of growth factors like VEGFA and PLGF, which are critical for fetal development.  It is located within the uterus and is the primary location where fetal development occurs. Additionally, the placenta is often studied in relation to malaria research due to its role in fetal development and susceptibility to infection. \n\",4\n3232,MEDICALLY TERMINATED PREGNANCY,A pregnancy that is ended by medical intervention,4\n3222,VEGFR,\"The **VEGFR** (Vascular Endothelial Growth Factor Receptor) is a receptor that binds to the protein Vascular Endothelial Growth Factor (VEGF). This binding plays a crucial role in **angiogenesis**, the process of forming new blood vessels.  VEGFR helps with blood vessel formation by triggering cellular signaling pathways that promote angiogenesis. \n\",1\n3408,CANCER PROGRESSION,,1\n3821,SIHA CELLS,A type of cell,2\n3823,M2,\"The **M2** compound exhibits potent inhibitory activity against VEGF protein secretion.  This inhibition is linked to macrophage polarization towards the M2 phenotype, a subtype of macrophages known for its anti-inflammatory and tissue repair properties. \n\",6\n3822,VEGF PROTEIN,Protein involved in angiogenesis,2\n3825,IC<SUB>50</SUB> VALUE,,2\n3826,INHIBITION ACTIVITY,,2\n349,PLGF,\"The **PLGF** (Placental Growth Factor) is a growth factor that contributes to pathological angiogenesis, meaning the abnormal formation of blood vessels. It also plays a role in promoting angiogenesis, which is the process of new blood vessel formation.  Furthermore, PLGF is loaded into cells during placental development. \n\",3\n4693,HUMAN COLORECTAL ADENOCARCINOMA CELLS,Cells used in a study,3\n1441,HCVECS,Hypoxic human choroidal vascular endothelial cells,1\n1443,MOUSE CNV,A model of cardiovascular disease,1\n1444,HIF-1Α/VEGF,,1\n2226,EIF4A3,\"The **EIF4A3** protein is a key player in the field of glioma research. It plays a role in regulating gene expression, making it relevant to understanding how cells function and potentially contributing to the development of cancer treatments. \n\",2\n3139,CCL2,,2\n3824,PAB,Lead compound with lower inhibitory activity against VEGF protein secretion,4\n449,TUMOR METASTASIS,\"**Tumor metastasis** is the process by which cancer cells spread from a primary tumor to other parts of the body. This spread, also known as **dissemination**, occurs when cancer cells break away from the original tumor and travel through the bloodstream or lymphatic system to establish new tumors in distant locations.  It is a significant factor in the progression and severity of many cancers. \n\",1\n2123,TUMOR FORMATION,Process of tumor growth,1\n791,M2 MACROPHAGES,\"Macrophages are involved in the inflammatory response and tissue repair\nMacrophages that are involved in the inflammatory response and tissue repair\",3\n4622,GLAUCINE,\"Glaucine is a chemical compound with anti-inflammatory, bronchodilator and anti-cancer activities\",4\n4623,ARPE-19 CELLS,Cells used in the study of glaucine's effects on AMD,1\n4628,ARPE-19,A human retinal pigment epithelial cell line commonly used for studying AMD,1\n4691,PROPANOOL,β-adrenergic receptor antagonist,2\n4692,LY2157299,Inhibitor of TGF-β receptor Type I kinase,2\n932,AMD,\"**AMD (Age-related macular degeneration)** is a medical condition that causes vision loss. It is a condition studied in research and is characterized by the deterioration of the macula, the central part of the retina responsible for sharp, detailed vision.  AMD can lead to significant visual impairment, impacting daily life activities such as reading, driving, and recognizing faces. \n\",4\n5240,THERAPEUTIC APPROACH,Potential method to manage inflammatory processes,1\n417,ENDOTHELIAL GALECTINS,Endothelial galectins are a focus of research on tumor progression,1\n418,TUMOR PROGRESSION,\"**Tumor progression** is a biological process that describes the growth and spread of a tumor.  It encompasses both the initial stages of tumor development, known as **tumor growth**, and the subsequent expansion of the tumor into surrounding tissues, often leading to metastasis. This process can be characterized by various factors including cell proliferation, angiogenesis (formation of new blood vessels), and invasion of surrounding tissues. \n\",3\n2172,RGD-PEPTIDE NANOPARTICLES,Nanoparticles used for targeted delivery of siRNA,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n752,PSC CELLS,VEGF,VEGF secretion was reduced by USP9X in PSC cells,43\n834,TUMOR ANGIOGENESIS,EVENT,\"Rapid progression of tumor angiogenesis is necessary for tumor growth\nMany mechanisms driving this process are unclear\",24\n346,GLIOMA,VEGFA,Resistance to anti-angiogenic drug VEGFA antibody correlates with Glioma resistance,22\n349,VEGFA,IDO1,IDO1 is related to tumor angiogenesis and may be a factor in the resistance to anti-angiogenic drugs,19\n1260,YTHDC2,VEGFA,\"The **YTHDC2** protein plays a role in angiogenesis, specifically promoting tube formation.  It achieves this by binding to **VEGFA**, a growth factor that is crucial for blood vessel development. Research has also shown that YTHDC2 influences the expression of **VEGFA** in human umbilical vein endothelial cells (HUVECs). \n\",19\n619,TYPE 3 MACULAR NEOVASCULARIZATION,EVENT,Type 3 macular neovascularization is a condition that can be detected by OCT scans,18\n883,MIR-1249,VEGFA,miR-1249 promotes glioma via the miR-1249/VEGFA axis,18\n1164,AKT,VEGFA,\"AKT inhibits the AKT-VEGFA signaling pathway, which is involved in placental angiogenesis\",17\n873,CIRC_0059914,RESEARCH,Circ_0059914 is being studied for its role in glioma,16\n1263,AC092100.1,HUVEC,\"AC092100.1 promotes HUVEC proliferation, migration, and tube formation in vitro\nOverexpression of AC092100.1 promotes HUVEC proliferation, migration, and tube formation in vitro\",16\n538,CBX7,HIF-1Α,CBX7 upregulates HIF-1α,14\n1010,HUVEC,EXOSOME,\"Exosomes are ingested by HUVECs, which increases miR-558 expression and enhances cell functions\",14\n1011,HUVEC,MATRIGEL PLUG,HUVECs are used to study cell growth using Matrigel plugs,14\n2101,HUVEC,TUBE-FORMING ASSAY,HUVEC tube formation assay was used to detect the effect of Apelin-13 on angiogenesis,14\n2106,HUVEC,APJ,HUVECs express the APJ receptor for Apelin-13,14\n1937,NE,HIF-1Α,Norepinephrine stimulates HIF-1α expression,13\n831,OVARIAN CANCER SIDE POPULATION (SP),TUMOR ANGIOGENESIS,\"CSCs contribute to tumor angiogenesis\nCSCs play a role in tumor angiogenesis\",12\n1262,PE,HIF-1Α,HIF-1α is a marker for mesenchymal morphology and is studied in the PE mouse model,12\n351,IDO1,TUMOR ANGIOGENESIS,IDO1 has been suggested to be related to tumor angiogenesis,11\n543,HYPOXIC CVECS,HIF-1Α,\"Hypoxic CVECs upregulate HIF-1α, contributing to CNV formation\",11\n830,OVARIAN CANCER,OVARIAN CANCER SIDE POPULATION (SP),\"CSCs contribute to tumor growth\nCSCs contribute to tumor formation, colony formation, xenograft tumor formation, ascites formation, and tumor metastasis\nCSCs play a role in tumor formation, colony formation, xenograft tumor formation, ascites formation, and tumor metastasis\",11\n847,EC TARGET DELIVERY,TUMOR ANGIOGENESIS,\"The process of delivering Hif1α/Hk2-siRNAs to knockdown gene expression in tumor cells, which restricts tumor growth\",11\n542,HIF-1Α,CVECS,CVECs upregulate HIF-1α,10\n1777,HLA-G,HIF-1Α,\"HLA-G and HIF-1α expressions were correlated in hypoxic BM, but not in oxygenated tissues\",10\n1433,OV-EVS,OVARIAN CANCER,\"OV-EVs induce M2 polarization in macrophages, promoting ovarian cancer progression\",9\n1299,CAFS,PODOPLANIN,CAF subpopulations with pro-angiogenic functions are labeled by PDPN,8\n1359,RECURRENT PREGNANCY LOSS,PLACENTA,Women with recurrent pregnancy loss have placenta tissue collected for analysis,8\n1363,MEDICALLY TERMINATED PREGNANCY,PLACENTA,Placenta tissue from women who had medically terminated pregnancies is used for comparison,8\n1435,OVARIAN CANCER,VEGFR,\"OV-EVs increase VEGFR expression, promoting angiogenesis in ovarian cancer\",8\n1438,OVARIAN CANCER,CANCER PROGRESSION,OV-EVs induce M2 polarization and promote cancer progression in ovarian cancer,8\n1614,SIHA CELLS,M2,Compound M2 inhibited VEGF protein secretion in SiHa cells under hypoxic conditions,8\n1616,VEGF PROTEIN,M2,Compound M2 inhibited VEGF protein secretion,8\n1618,M2,IC<SUB>50</SUB> VALUE,\"Compound M2 exhibited potent inhibitory activity against VEGF protein secretion\nCompound M2 had an IC<sub>50</sub> value of 0.68 μM\",8\n1619,M2,INHIBITION ACTIVITY,Compound M2 exhibited potent inhibitory activity against VEGF protein secretion,8\n1006,PLACENTA,TROPHOBLAST,Placenta and trophoblast cells work together during pregnancy,7\n1361,RECURRENT PREGNANCY LOSS,PLGF,Downregulation of PLGF gene expression is observed in the placenta of women with recurrent pregnancy loss,7\n1940,NE,HUMAN COLORECTAL ADENOCARCINOMA CELLS,NE was used to treat tumor growth and vessel density in human colorectal adenocarcinoma cells,7\n537,HCVECS,CBX7,\"CBX7 promotes the migration, proliferation, and tube formation of HCVECs\",6\n540,CBX7,MOUSE CNV,CBX7 down-regulates Mouse CNV,6\n541,CBX7,HIF-1Α/VEGF,CBX7 enhances pro-angiogenic behaviors of hypoxic CVECs by up-regulating HIF-1α/VEGF,6\n885,EIF4A3,CIRC_0059914,EIF4A3 increases the expression of circ_0059914,6\n1300,CAFS,CCL2,CAF subpopulations maintain CAF heterogeneity through CCL2 autocrine signaling,6\n1303,PODOPLANIN,CCL2,\"PDPN and CCL2 form a feedback loop for CAF subpopulation maintenance\nPodoplanin and CCL2 form a feedback loop for CAF subpopulation maintenance\",6\n1620,PAB,IC<SUB>50</SUB> VALUE,\"Lead compound PAB did not exhibit potent inhibition of VEGF protein secretion\nLead compound PAB had an IC<sub>50</sub> value of 5.44 μM\",6\n832,OVARIAN CANCER SIDE POPULATION (SP),TUMOR METASTASIS,CSCs contribute to tumor metastasis,5\n833,OVARIAN CANCER SIDE POPULATION (SP),TUMOR FORMATION,CSCs play a role in tumor formation,5\n1430,M2 MACROPHAGES,OV-EVS,M2 macrophages are activated by OV-EVs and promote cancer progression,5\n1910,GLAUCINE,ARPE-19 CELLS,Glaucine was tested on ARPE-19 cells to investigate its effects on AMD,5\n1912,GLAUCINE,ARPE-19,Glaucine attenuated the production of IL-6 and MCP-1 in ARPE-19 cells,5\n1941,PROPANOOL,HUMAN COLORECTAL ADENOCARCINOMA CELLS,Propranolol was used to treat tumor growth and vessel density in human colorectal adenocarcinoma cells,5\n1942,LY2157299,HUMAN COLORECTAL ADENOCARCINOMA CELLS,Ly2157299 was used to inhibit TGF-β receptor Type I kinase in human colorectal adenocarcinoma cells,5\n2204,AMD,THERAPEUTIC APPROACH,AMD could be treated with a therapeutic approach,5\n169,ENDOTHELIAL GALECTINS,TUMOR PROGRESSION,Endothelial galectins are involved in tumor progression,4\n846,RGD-PEPTIDE NANOPARTICLES,EC TARGET DELIVERY,Used for targeted delivery of siRNA to tumor cells,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_0838dec4b841e9cebff3bf7b9de2ba6569261a5c9fad392908ccad866dcb00ed_v2"}